Lehman Brothers
View Older Stories View More Recent Stories
-
Euler Hermes Group announces CEO leadership change
-
UBS and Banco do Brasil Launch UBS BB Investment Bank and Unveil the Firm’s Leadership Team
-
Lehman Brothers UK Capital Funding IV LP: Notice of Proposed Interim Payment
-
Lehman Brothers UK Capital Funding V LP: Notice of Proposed Interim Payment
-
Scientific Games (SGMS) Names Tim Throsby to Board
-
Scientific Games Announces Tim Throsby To Serve As New Independent Member Of The Board Of Directors
-
Enigma Securities Work With Bloomberg To Provide Research To Bloomberg Terminal
-
Form 8-K LEHMAN BROTHERS HOLDINGS For: Sep 24
-
Option3Ventures Announces the Successful Launch of its Cybersecurity Special Purpose Vehicle Situations Portfolio with Three New Investments
-
Twenty-First Distribution Percentages Announced for Lehman Brothers Holdings Inc. and Its Debtor Affiliates
-
Next Coast Ventures Expands Team with Anthony Walker as Principal
-
Ara Partners Expands Senior Investment Team with Addition of Seasoned Private Equity Executive
-
Aravive Inc. (ARAV) Michael W. Rogers to Board
-
Aravive Appoints Michael W. Rogers to Board of Directors
-
Party City Appoints Two New Independent Directors to Board
-
John Rhea Joins Centerview Partners
-
Fintech Startup, Flaist, Launches New Technology that Gives Banking and Financial Institutions AI Customer Service Agents
-
Perella Weinberg Partners Names Woody Young Chairman of Mergers & Acquisitions
-
Common Securitization Solutions Names Juanita Russell Chief Financial Officer and Jina Hong Chief Audit Executive
-
TAG Oil Announces Management and Board Appointments, Private Placement and Stock Option Grants
-
Lockton Companies Announces Pradip Ghosh as President of Lockton Capital Markets
-
Dark3 Inc. Secures Series A Financing Round Led by Cybersecurity Investment Specialists, Option3Ventures
-
DiamondRock Hospitality Company Appoints Michael A. Hartmeier to Board of Directors
-
Pandemic may push Japan banks' credit costs to crisis levels: BOJ's Suzuki
-
Chambers USA Ranked Bankruptcy Attorney Robbin Itkin Moves from DLA Piper to Sklar Kirsh
-
Gemspring Capital Adds to Team With Three Strategic Hires
-
Fate Therapeutics (FATE) Announces Edward Dulac as CFO
-
Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer
-
Fate Therapeutics Appoints Edward Dulac as Chief Financial Officer
-
Suraj Badlani appointed as CFO and Head of Corporate Development of Chargebacks911 and Fi911
-
Japan's record economic plunge wipes out Abe era gains
-
Avis Budget Group (CAR) announces John F. North III will transition from CFO, Brian Choi will assume role
-
Avis Budget Group Announces Chief Financial Officer Transition
-
Avis Budget Group Announces Chief Financial Officer Transition
-
Terns Pharmaceuticals Appoints Senthil Sundaram as Chief Executive Officer, Mark Vignola, Ph.D., as Chief Financial Officer, and Erin Quirk, M.D., as President
-
8i Enterprises Acquisition Corp. Announces That Its Intended Merger Target – Diginex Appoints New Chairman, Chi-Won Yoon
-
8i Enterprises Acquisition Corp. Announces That Its Intended Merger Target – Diginex Appoints New Chairman, Chi-Won Yoon
-
Ross Hammerman Joins Perella Weinberg Partners as Partner
-
Form 8-K LEHMAN BROTHERS HOLDINGS For: Jul 30
-
JMP Group Announces Management Changes
-
Rohit Bharill Joins Cadence as Head of Risk
-
POWER REIT PROVIDES COMPANY UPDATE
-
POWER REIT PROVIDES COMPANY UPDATE
-
East Daley Capital Hires Ethan Bellamy to Lead Midstream Energy Market Strategy
-
Advisor Group Welcomes Richard Page To Ladenburg Thalmann & Co. Inc. As Managing Director In Healthcare Investment Banking Group
-
CT-based Procyon Partners Doubles Down in the Big Apple: Adds Veteran Financial Advisor Steven Mitchell in NYC
-
American Discovery Capital Acquires Clear Capital Advisors
-
AZTherapies Strengthens Board of Directors & Business Advisory Board with New Appointments
-
Matrix Executions Adds Chief Revenue Officer as Advocate for Clients’ Multi-Asset Needs
-
Tenax Therapeutics Expands Board of Directors with the Appointment of Two New Directors, Steven Boyd and Keith Maher, MD
